Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

NCT01531777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Apatinib
DRUG: apatinib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]